跳至主要内容
临床试验/NCT06121609
NCT06121609已完成不适用

The 90% Effective Dose (ED90) of Remimazolam Anesthesia Induction in Painless Bidirectional Endoscopy in Children: a Biased Coin up and Down Sequential Trial

Tongji Hospital1 个研究点 分布在 1 个国家目标入组 165 人开始时间: 2024年1月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
165
试验地点
1
主要终点
Modified Observer's Assessment of Alertness/Sedation Scale, MOAA/S

研究概览

简要总结

Exploring the ED90 of remimazolam in pediatric bidirectional endoscopy at different age groups.

详细描述

Exploring the ED90 of remimazolam in pediatric bidirectional endoscopy at different age groups, providing a more scientific clinical dose selection basis for the anesthesia induction application of Remazolam.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
— 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age 0-12 years old,
  • ASA I-II level;
  • Sign an informed consent form.

排除标准

  • Developmental delay or neurological and psychiatric disorders;
  • Severe malnutrition or severe obesity;
  • High risk of stomach fullness and reflux aspiration;
  • Allergic to benzodiazepines and opioids;
  • Those who have taken sedative, analgesic, or antidepressant drugs within 24 hours;
  • Severe sleep apnea;
  • Abnormal liver and kidney function;
  • Recently participated in other clinical studies.

研究组 & 干预措施

4-6 years group

Experimental

Age: ≥48 and <84 months

干预措施: Remimazolam (Drug)

7-12 years group

Experimental

Age: ≥84and <156 months

干预措施: Remimazolam (Drug)

infant group

Experimental

Age: <48 months

干预措施: Remimazolam (Drug)

结局指标

主要结局

Modified Observer's Assessment of Alertness/Sedation Scale, MOAA/S

时间窗: The entire duration of anesthesia:From the start of drug administration for induction until the patient's awakening.

Using the modified MOAA/S scoring table(ranging from 5-0) to evaluate if the sedation is successful. 5 points:Respond quickly to names spoken in a normal tone 4 points:Showing a drowsy reaction to names spoken in a normal tone 3 points:Only react after loudly and/or repeatedly calling the name 2 points:Response immediately after slight stimulation or shaking 1point:Response only occurs after compression of the trapezius muscle that causes pain 0 point:No response after compression of the trapezius muscle

次要结局

  • Respiratory Suppression Incidence(The entire duration of anesthesia:From the start of drug administration for induction until the patient's awakening.)
  • Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability](From the start of drug administration for induction to 24h after the operation.)
  • Time Records(The entire duration of anesthesia:From the start of drug administration for induction until the patient's awakening.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

aijun xu

Doctor

Tongji Hospital

研究点 (1)

Loading locations...

相似试验